Taro Pharmaceutical Industries

Taro Pharmaceutical Industries

TARO

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.62B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Taro Pharmaceutical IndustriesTaro Pharmaceutical Industries30-3%2.7-
$30.70

Current Fair Value

28.6% downside

Overvalued by 28.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.62 Billion
Enterprise Value$1.25 Billion
Dividend Yield$- (-)
Earnings per Share$1.43
Beta0.56
Outstanding Shares37,584,891

Return

Return on Equity3.00%ROE
Return on Assets2.49%
Return on Invested Capital1.22%

Valuation & Multiples

P/E Ratio29.99P/E Ratio
PEG25.39PEG
Price to Sales2.69Price to Sales
Price to Book Ratio0.91Price to Book Ratio
Enterprise Value to Revenue1.99
Enterprise Value to EBIT57.07
Enterprise Value to Net Income23
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Taro Pharmaceutical Industries

CEO: Uday Baldota